Ann Surg 270(6):937-941, 2019
Tirzepatide is a next-generation medication designed to support weight loss by targeting multiple pathways involved in appetite and metabolism
Regarding background therapy, patients were receiving a mean of 1.9 1.0 glucose-lowering agents in addition to OW semaglutide
Once you have the name, search your state's board of pharmacy to see if it's licensed in your state, then check whether it's accredited by the National Association of Boards of Pharmacy via their website
If you are regularly missing doses, consider adjusting your injection day to one that better fits your routine, or set multiple reminders
It isnt the right choice for everyone, though, especially for those with certain health conditions like a history of thyroid cancer or pancreatitis